Intervention is needed in polycystic ovary syndrome for prevention of cardiovascular diseases - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Addressing Polycystic Ovary Syndrome to Mitigate Cardiovascular Disease Risk

  • By

  • Felice L Gersh

  • Carl J Lavie

  • James H O’Keefe

  • January 11, 2025

Share

  • 1

    Polycystic ovary syndrome (PCOS) affects 5–10% of reproductive-age women and is linked to increased cardiovascular disease (CVD) risk.

  • 2

    A study found that women with PCOS had a 77% higher risk of CVD, with non-obese women showing a two-fold increase in coronary artery disease.

  • 3

    Conventional treatments for PCOS, including hormonal contraceptives and metformin, showed no positive impact on cardiovascular outcomes.

  • 4

    New therapeutic approaches, such as oestradiol and GLP-1 receptor agonists, are needed to address CVD risk in women with PCOS.

  • 5

    Lifestyle modifications alongside pharmacotherapy are essential for improving cardiovascular health in both obese and non-obese women with PCOS.

Original Source(s)

Intervention is needed in polycystic ovary syndrome for prevention of cardiovascular diseases

  • by Felice L Gersh, Carl J Lavie, James H O’Keefe

  • January 11, 2025

Related Content

What’s new in point-of-care lung ultrasound: reading the new recommendations

Predicting Neonatal Hypoxia in dTGA/IVS Remains Challenging, Heightens Need for High-Risk Delivery Planning

Christopher Lindblade, MD, co-author of a 2026 Journal of the American Society of Echocardiography study, shares how factors seen on fetal echocardiography support the Phoenix Children’s model for performing urgent bedside balloon atrial septostomy for babies with neonatal hypoxia.

  • by

  • October 15, 2026

  • 7 min
Influence of left ventricular ejection fraction on the clinical outcome of percutaneous coronary interventions in heart transplant patients